JPMorgan Chase Investing Cash Flow decreased by 921.9% to -$217.77B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 84.4%, from -$118.08B to -$217.77B.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $17.70B | -$62.28B | -$100.16B | -$72.61B | -$53.20B | -$51.53B | $23.79B | -$17.79B | $79.88B | -$43.38B | -$94.24B | -$43.41B | -$118.08B | -$173.06B | -$21.31B | -$217.77B |
| QoQ Change | — | -451.9% | -60.8% | +27.5% | +26.7% | +3.1% | +146.2% | -174.8% | +549.0% | -154.3% | -117.2% | +53.9% | -172.0% | -46.6% | +87.7% | -921.9% |
| YoY Change | — | — | — | — | -400.6% | +48.6% | +132.8% | — | +255.0% | -282.3% | — | -144.0% | -172.2% | -83.6% | +50.9% | -84.4% |